Researchers from ETH Zurich have succeeded in introducing large quantities of unnatural amino acids into bacteria, enabling ...

Colibactin is a powerful toxin produced by Escherichia coli and other bacteria living in the human gut. This highly unstable ...

Evo’s success wasn’t limited to proteins. When they tested a different toxin that had an RNA-based inhibitor, the system ...

Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...

Northwestern Medicine investigators have identified issues with most genomic sequence data for the Neisseria gonorrhoeae ...

Nobody wants harmful bacteria colonizing the surfaces of objects such as medical implants, yet we also don't want them building up a resistance to antibiotics. Well, help may be on the way, in the ...

A closeup look at colibactin’s structure reveals chemical motifs that guide its mutation-wreaking “warheads” to specific stretches of DNA.

Researchers suggest targeting the fatty coat of tuberculosis bacteria could enhance the effectiveness of existing TB ...

The tiny pantheon known as the Asgard archaea bear traits that hint at how plants, animals and fungi emerged on Earth.

The multidrug-resistant pathogen Acinetobacter baumannii (A. baumannii) is a global health concern. Its surface capsular ...

The bacteria Mycobacterium tuberculosis, which causes the world's most infectious disease Tuberculosis (TB), can survive ...

After a patient's death, the state health department found germs that cause Legionnaires’ disease in the water at St.